DFFVX
Price
$36.48
Change
-$0.05 (-0.14%)
Updated
Sep 15 closing price
Net Assets
13.81B
RVVHX
Price
$10.91
Change
-$0.03 (-0.27%)
Updated
Sep 15 closing price
Net Assets
104.32M
Interact to see
Advertisement

DFFVX vs RVVHX

Header iconDFFVX vs RVVHX Comparison
Open Charts DFFVX vs RVVHXBanner chart's image
DFA US Targeted Value I
Price$36.48
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets13.81B
Royce Small-Cap Value Investment
Price$10.91
Change-$0.03 (-0.27%)
VolumeN/A
Net Assets104.32M
DFFVX vs RVVHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DFFVX vs. RVVHX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and RVVHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.8B vs. RVVHX (104M). DFFVX pays higher dividends than RVVHX: DFFVX (1.50) vs RVVHX (1.10). DFFVX was incepted earlier than RVVHX: DFFVX (26 years) vs RVVHX (19 years). RVVHX (1.34) is less costly to investors than DFFVX (0.30). RVVHX is a more actively managed with annual turnover of: 43.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than RVVHX: DFFVX (0) vs RVVHX (2000). DFFVX annual gain was more profitable for investors over the last year : 11.82 vs. RVVHX (4.36). DFFVX return over 5 years is better than : 105.68 vs. RVVHX (58.05).
DFFVXRVVHXDFFVX / RVVHX
Total Expense Ratio0.291.2423%
Annual Report Gross Expense Ratio0.301.3422%
Fund Existence26 years19 years-
Gain YTD7.2648.44986%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.8B104M13,269%
Annual Yield % from dividends1.501.10136%
Returns for 1 year11.824.36271%
Returns for 3 years39.5327.30145%
Returns for 5 years105.6858.05182%
Returns for 10 years85.158.76972%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHSZX43.40N/A
N/A
PGIM Jennison Health Sciences Z
PQUAX12.87N/A
N/A
PACE Small/Medium Co Growth Equity A
FZALX29.61N/A
N/A
Fidelity Advisor Mega Cap Stock Z
GSVPX17.02N/A
N/A
Goldman Sachs Small/Mid Cap Equity P
NUEIX23.26N/A
N/A
Northern US Quality ESG I